The dynamics of angiogenic factors and their soluble receptors in relation to organ dysfunction in disseminated intravascular coagulation associated with sepsis

Inflammation

Volumn 36, Issue 1, 2013, Pages 186-196

  Jesmin, Subrina ^a,b,c   Wada, Takesi ^a   Gando, Satoshi ^a   Sultana, Sayeeda Sayeeda ^c   Zaedi, Sohel ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

angiopoietin; disseminated intravascular coagulation (DIC); organ dysfunction; sepsis; vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; FIBRIN; LACTIC ACID; THROMBIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DYNAMICS; FEMALE; HUMAN; HYPOXEMIA; LACTATE BLOOD LEVEL; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOGENESIS; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVOR; THROMBOCYTE COUNT; THROMBOCYTE METABOLISM;

ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; BLOOD PLATELETS; CELL HYPOXIA; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRIN; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET COUNT; PROSPECTIVE STUDIES; ROC CURVE; SEPSIS; THROMBIN; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 84872892978     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9534-6     Document Type: Article

References (37)

1. Levi, M., and H. ten Cate. 1999. Disseminated intravascular coagulation. The New England Journal of Medicine 341: 586-592. (Pubitemid 29384168)
2. Gando, S. 2010. Microvascular thrombosis and multiple organ dysfunction syndrome. Critical Care Medicine 38(Suppl): S35-S42.
3. Taylor Jr., F.B., C.H. Toh, W.K. Hoots, H. Wada, and M. Levi. 2001. Toward definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thrombosis and Haemostasis 86: 1327-1330.
4. Oda, M., J.Y. Han, and M. Nakamura. 2000. Endothelial cell dysfunction in microvasculature: Relevance to disease processes. Clinical Hemorheology and Microcirculation 23: 199-211. (Pubitemid 32274605)
5. Takahashi, H., and M. Shibuya. 2005. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clinical Science 109: 227-241. (Pubitemid 41337127)
6. Olsson, A.K., A. Dimberg, J. Kreuger, and L. Claesson-Welsh. 2006. VEGF receptor signaling - In control of vascular function. Nature Reviews Molecular Cell Biology 7: 359-371.
7. Pugh, C.W., and P.J. Ratcliffe. 2003. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nature Medicine 9: 677-684. (Pubitemid 36749216)
8. Tsopanoglou, N.E., and M.E. Maragoudakis. 2004. Role of thrombin in angiogenesis and tumor progression. Seminars Thrombosis and Haemostasis 30: 63-69. (Pubitemid 38457301)
9. Augustin, H.G., G.Y. Koh, G. Thurston, and K. Alitalo. 2009. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nature Reviews Molecular Cell Biology 10: 165-177.
10. Fiedler, U., and H.G. Augstin. 2006. Angiopoietins: A link between angiogenesis and inflammation. Trends in Immunology 27: 552-558. (Pubitemid 44780853)
11. Bae, J.S., and A.R. Rezaie. 2010. Thrombin upregulates the angiopoietin-Tie2 axis: Endothelial protein C receptor occupancy prevents the thrombin mobilization of angiopoietin 2 and P-selectin from Weibel-Palade bodies. Journal of Thrombosis and Haemostasis 8: 1107-1115.
12. Oh, H., H. Takagi, K. Suzuma, A. Otani, M. Matsumura, and Y. Honda. 1999. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. The Journal of Biological Chemistry 274: 15732-15739. (Pubitemid 29254948)
13. Kim, I., J.L. Oh, Y.S. Ryu, J.N. So, W.C. Sessa, K. Walsh, et al. 2002. Angipoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells. The FASEB Journal 16: 126-128.
14. Brindle, N.P.J., P. Saharinen, and K. Alitalo. 2006. Signaling and functions of angiopoetin-1 in vascular protection. Cirurgica Research 98: 1014-1023.
15. Shapiro, N.I., K. Yano, H. Okada, C. Fischer, M. Howell, K.C. Spokes, et al. 2008. A prospective, observational study of soluble Flt-1 and vascular endothelial growth factor in sepsis. Shock 29: 452-457. (Pubitemid 351416810)
16. Alves, B.E., S.A. Montalvao, F.J.P. Aranha, I. Lorand-Metze, C.A. De Souza, J.M. Annichino-Bizzacchi, et al. 2011. Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: A prospective study. Journal Transactions Medicine 9: 23.
17. Yang, K.Y., K.T. Liu, Y.C. Chen, C.S. Chen, Y.C. Lee, R.P. Peng, et al. 2011. Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: A prospective observational study. Critical Care 15: R11.
18. Kümpers, P., A. Lukasz, S. David, R. Horn, C. Hafer, R. Faulhaber-Walter, et al. 2008. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Critical Care 12: R147.
19. Karlsson, S., V. Pettilä, J. Tenhunen, V. Lund, S. Hovilehto, and E. Ruokonen. 2008. Vascular endothelial growth factor in severe sepsis and septic shock. Anesthesia and Analgesia 106: 1820-1826.
20. Mankhambo, L.A., D. Banda, G. Jeffers, S.A. White, P. Balmer, S. Nkhoma, et al. 2010. The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children. Critical Care 14: R91.
21. van der Flier, M., H.J. van Leeuwen, K.P. van Kessel, J.L. Kimpen, A.I. Hoepelman, and S.P. Geelen. 2005. Plasma vascular endothelial growth factor in severe sepsis. Shock 23: 35-38. (Pubitemid 40083025)
22. Pickkers, P., T. Sprong, L. van Eijk, H. van der Hoeven, P. Smits, and M. van Deuren. 2005. Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock 24: 508-512.
23. Yano, K., P.C. Liaw, J.M. Mullington, S.C. Shih, H. Okada, N. Bodyak, et al. 2006. Vascualr endothelial growth factor in an important determinant of sepsis morbidity and mortality. The Journal of Experimental Medicine 203: 1447-1458. (Pubitemid 43877607)
24. Orfanos, S.E., A. Kotanidou, C. Glynos, C. Athanasiou, S. Tsigkos, I. Dimopoulou, et al. 2007. Angiopoietin-2 is increased in severe sepsis: Correlation with inflammatory mediators. Critical Care Medicine 35: 199-206. (Pubitemid 46035696)
25. Giuliano, J.S., P.M. Lahni, K. Harmon, H.R. Wong, L.A. Doughty, J.A. Carcillo, et al. 2007. Admission angiopoietin levels in children with septic shock. Shock 28: 650-654. (Pubitemid 350135468)
26. Ricciuto, D.R., C.C. dos Santos, M. Hawkes, L.J. Toltl, A.L. Conroy, N. Rajwans, et al. 2011. Angiopoietin-1 and angiopoietin-2 as clinical informative prognostic biomarkers of morbidity and mortality in severe sepsis. Critical Care Medicine 39: 702-710.
27. Knaus, W.A., E.A. Draper, D.P. Wanger, and J.E. Zimmerman. 1985. APACHE II: A severity classification system. Critical Care Medicine 13: 818-829.
28. Ferreira, F.L., D.P. Bota, A. Bross, C. Mélot, and J.L. Vincent. 2001. Serial evaluation of the SOFA score to predict outcome in critically ill patients. Journal of the American Medical Association 286: 1754-1758. (Pubitemid 33010262)
29. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference committee. 1992. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definition for sepsis and organ failure and guidelines for the use innovative therapies in sepsis. Critical Care Medicine 20: 864-874.
30. Gando, S., D. Saitoh, H. Ogura, T. Mayumi, K. Koseki, T. Ikeda, et al. 2008. Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) study group. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey. Critical Care Medicine 36: 145-150.
31. Webb, N.J.A., M.J. Bottomley, C.J. Watson, and P.C. Brenchiley. 1998. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease. Clinical Science 94: 395-404. (Pubitemid 28176624)
32. Verheul, H.M.W., K. Hoekman, S. Luykx-de Bakker, C.A. Eekman, C.C. Folman, H.J. Broxterman, et al. 1997. Platelet: Transporter of vascular endothelial growth factor. Clinical Cancer Research 3: 2187-2190. (Pubitemid 28133134)
33. Kusumoto, Y.H., W.A. Dam, G.A.P. Hospers, C. Meijer, and N.H. Mulder. 2003. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 6: 283-287. (Pubitemid 38987537)
34. Möhle, R., D. Green, M.A.S. Moore, R.L. Nachman, and S. Rafii. 1997. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proceedings NationalAcademia Science USA 94: 663-668. (Pubitemid 27053690)
35. Tsao, P.N., F.T. Chan, S.C. Wei, W.S. Hsieh, H.C. Chou, Y.N. Su, et al. 2007. Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis. Critical Care Medicine 35: 1955-1960. (Pubitemid 47220372)
36. Reusch, P., B. Barleon, K. Weindel, G. Martiny-Baron, A. Godde, G. Siemeister, et al. 2001. Identification of soluble form of angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis 4: 123-131. (Pubitemid 34032698)
37. van der Heijden, M., G.P. van Nieuw Ameorongen, V.W.M. van Hinsbergh, and A.B. Johan Groeneveld. 2010. The interaction of soluble Tie2 with angiopoietin and pulmonary vascular permeability in septic and non septic critically ill patients. Shock 33: 263-268.